From Wikipedia, the free encyclopedia
Jump to: navigation,
search
Moexipril
 |
| Systematic (IUPAC) name |
| (3S)-2-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
| Clinical data |
| Trade names |
Univasc |
| AHFS/Drugs.com |
monograph |
| MedlinePlus |
a695018 |
| Pregnancy cat. |
D(US) |
| Legal status |
POM (UK) ℞-only (US) |
| Routes |
Oral |
| Identifiers |
| CAS number |
103775-10-6 Y |
| ATC code |
C09AA13 |
| PubChem |
CID 91270 |
| DrugBank |
DB00691 |
| ChemSpider |
82418 N |
| UNII |
WT87C52TJZ N |
| KEGG |
D08225 Y |
| ChEMBL |
CHEMBL1165 N |
| Chemical data |
| Formula |
C27H34N2O7 |
| Mol. mass |
498.568 g/mol |
N(what is this?) (verify)
|
Moexipril (marketed under the tradenames Univasc and Perdix1) is an ACE inhibitor.2
References
- ^ Dart, Richard C. (2004). Medical toxicology. Lippincott Williams & Wilkins. p. 647. ISBN 9780781728454. http://books.google.ca/books?id=BfdighlyGiwC&pg=PA647. Retrieved 2009-10-09.
- ^ Hochadel, Maryanne, ed (2006). The AARP Guide to Pills. Sterling Publishing Company. p. 640. ISBN 9781402717406. http://books.google.ca/books?id=WvcaI-7TuaMC&pg=RA1-PA64. Retrieved 2009-10-09.
|
Antihypertensives: agents acting on the renin-angiotensin system (C09)
|
|
ACE inhibitors
("-pril") |
Sulfhydryl-containing: Captopril • Zofenopril
Dicarboxylate-containing: Enalapril# • Ramipril • Quinapril • Perindopril • Lisinopril (+HCT) • Benazepril
Phosphonate-containing: Fosinopril
Other/ungrouped: Alacepril • Cilazapril • Delapril • Imidapril • Moexipril • Rentiapril • Spirapril • Temocapril • Trandolapril
|
|
AIIRAs/
("-sartan") |
Azilsartan • Candesartan • Eprosartan • Irbesartan • Losartan • Olmesartan • Tasosartan§ • Telmisartan (+HCT) • Valsartan (+HCT)
|
|
Renin inhibitors/
("-kiren") |
Aliskiren (+amlodipine) • Remikiren§
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
anat(a:h/u/t/a/l,v:h/u/t/a/l)/phys/devp/cell/prot
|
noco/syva/cong/lyvd/tumr, sysi/epon, injr
|
proc, drug(C2s+n/3/4/5/7/8/9)
|
|
|
|